Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Valera seeks to begin clinical studies of VP-004 naltrexone implant

June 29, 2006

Pfizer patents novel nicotinic acetylcholine receptor modulators for promoting smoking cessation

June 29, 2006

Studies of NRP-104 pharmacokinetics, abuse potential reported

June 29, 2006

Preliminary results from phase II studies of cocaine vaccine TA-CD

June 28, 2006

Targeting the dopamine D3 receptor to block the reinforcing efficacy of nicotine

June 27, 2006

Novel human anticocaine monoclonal antibody limits cocaine distribution to the brain

June 26, 2006

bPiDDB blocks nicotine-induced dopamine release in the nucleus accumbens

June 26, 2006

NDA submission for Cyanokit for cyanide poisoning

June 23, 2006

Novel dopamine D3 receptor antagonists for drug dependence emerge from Bioprojet R&D

June 21, 2006

Vivitrol for alcohol dependence now available

June 15, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...